We are live on ! Find out more
VTRS icon

Viatris

472 hedge funds and large institutions have $12.8B invested in Viatris in 2017 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 195 increasing their positions, 167 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 195 | Existing positions reduced: 167

2.88% more ownership

Funds ownership: 72.96%75.84% (+2.9%)

12% less funds holding

Funds holding: 537472 (-65)

16% less capital invested

Capital invested by funds: $15.2B → $12.8B (-$2.42B)

35% less funds holding in top 10

Funds holding in top 10: 2013 (-7)

41% less call options, than puts

Call options by funds: $131M | Put options by funds: $222M

66% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 90

Holders
472
Holders Change
-65
Holders Change %
-12.1%
% of All Funds
11.77%
Holding in Top 10
13
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-35%
% of All Funds
0.32%
New
31
Increased
195
Reduced
167
Closed
90
Calls
$131M
Puts
$222M
Net Calls
-$90.9M
Net Calls Change
+$14.7M

VTRS Hedge Fund Activity: Q3 2017 in Review

472 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q3 2017, worth a combined $12.8B — down 16% from $15.2B a quarter earlier.

Sellers outnumbered buyers: 90 funds closed out of VTRS and 31 opened new positions — a net loss of 59 holders — while 167 trimmed existing stakes and 195 added.

The largest buyer was Pzena Investment Management, adding an estimated $352M. The largest seller was T. Rowe Price Associates, cutting an estimated $234M.

  • 472 institutional investors held Viatris (VTRS) as of Q3 2017, down from 537 in Q2 2017.
  • Funds reported $12.8B of Viatris stock for Q3 2017, down 16% quarter-over-quarter.
  • 31 funds opened new Viatris positions in Q3 2017 and 90 closed out, a net change of -59 holders.
  • The largest Viatris buyer in Q3 2017 was Pzena Investment Management, an estimated $352M added.
  • The largest Viatris seller in Q3 2017 was T. Rowe Price Associates, an estimated $234M sold.

Based on aggregated 13F filings for Q3 2017.